Maple Capital Management’s Idexx Laboratories IDXX Stock Holding History

Maple Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$247K	Hold	469	–	–	0.01%	105
2026 Q1	$264K	Sell	469 -64	-12%	-$41K	0.02%	100
2025 Q4	$361K	Buy	533 +4	+0.8%	+$2.72K	0.02%	91
2025 Q3	$338K	Sell	529 -39	-7%	-$23.7K	0.02%	91
2025 Q2	$305K	Sell	568 -5	-0.9%	-$2.39K	0.02%	95
2025 Q1	$241K	Buy	573 +5	+0.9%	+$2.17K	0.02%	109
2024 Q4	$235K	Hold	568	–	–	0.02%	101
2024 Q3	$287K	Hold	568	–	–	0.02%	98
2024 Q2	$277K	Sell	568 -37	-6%	-$18.6K	0.02%	102
2024 Q1	$327K	Hold	605	–	–	0.03%	90
2023 Q4	$336K	Hold	605	–	–	0.03%	78
2023 Q3	$265K	Hold	605	–	–	0.03%	85
2023 Q2	$304K	Sell	605 -20	-3%	-$9.58K	0.03%	80
2023 Q1	$313K	Sell	625 -8	-1%	-$3.83K	0.04%	79
2022 Q4	$258K	Buy	633 +4	+0.6%	+$1.55K	0.03%	82
2022 Q3	$269K	Sell	629 -15	-2%	-$5.51K	0.03%	82
2022 Q2	$226K	Sell	644 -16	-2%	-$6.52K	0.03%	85
2022 Q1	$361K	Sell	660 -5	-0.8%	-$2.63K	0.04%	78
2021 Q4	$438K	Hold	665	–	–	0.05%	74
2021 Q3	$414K	Hold	665	–	–	0.05%	74
2021 Q2	$447K	Sell	665 -20	-3%	-$11K	0.05%	75
2021 Q1	$335K	Hold	685	–	–	0.05%	76
2020 Q4	$342K	Sell	685 -6	-0.9%	-$2.69K	0.05%	78
2020 Q3	$313K	Hold	691	–	–	0.05%	81
2020 Q2	$228K	Buy	+691	New	+$200K	0.04%	93
2019 Q3	–	Sell	-734	Closed	-$202K	–	123
2019 Q2	$202K	Buy	+734	New	+$181K	0.05%	120

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Maple Capital Management's IDXX Position: Q2 2026 in Review

Maple Capital Management held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 469 shares worth $247K. The position accounts for 0.01% of the portfolio, ranked #105.

Maple Capital Management first reported a position in IDXX in Q2 2019 and has held it in 26 quarters since. The position peaked at $447K in Q2 2021. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Maple Capital Management held 469 shares of Idexx Laboratories worth $247K as of Q2 2026.
Maple Capital Management left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up 0.01% of Maple Capital Management's portfolio in Q2 2026, its #105 holding.
Maple Capital Management first reported a position in Idexx Laboratories in Q2 2019 and has held it in 26 quarters since.
Maple Capital Management's Idexx Laboratories position peaked at $447K in Q2 2021.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Maple Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.